SCHEDULE 13G 0002050895 XXXXXXXX LIVE Voting Common Stock, par value $0.0001 per share 12/31/2025 0001770069 MapLight Therapeutics, Inc. 56565P103 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 Rule 13d-1(d) Forbion Growth Opportunities Fund III Cooperatief U.A. b P7 0 3226400 0 3226400 3226400 N 7.1 OO Forbion Growth III Management B.V. b P7 0 3226400 0 3226400 3226400 N 7.1 OO MapLight Therapeutics, Inc. 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063 This statement is being filed by Forbion Growth Opportunities Fund III Cooperatief U.A. ("Forbion Growth III COOP") and Forbion Growth III Management B.V. ("Forbion Growth III"). Forbion Growth III COOP and Forbion Growth III are sometimes referred to collectively as the "Reporting Persons". The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands. Each of the Reporting Persons is organized under the laws of the Netherlands. Y Forbion Growth III COOP directly owns 3,226,400 shares of Common Stock of the Issuer. Forbion Growth III, as the director of Forbion Growth III COOP, may be deemed to have voting and investment power over the shares held directly by Forbion Growth III COOP. The shares of Common Stock beneficially owned by the Reporting Persons represent approximately 7.1% of the outstanding Common Stock, based upon 45,373,033 shares of Common Stock outstanding as of November 24, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q filed on December 4, 2025. 0 3,226,400 0 3,226,400 Y Y Y Y Y Y Forbion Growth Opportunities Fund III Cooperatief U.A. /s/ G.J Mulder and /s/ M.A. van Osch 02/17/2026 Forbion Growth III Management B.V. /s/ G.J Mulder and /s/ M.A. van Osch 02/17/2026